AVAMYS TM NASAL SPRAY
 Fluticasone furoate

QUALITATIVE AND QUANTITATIVE COMPOSISTION
AVAMYS  Nasal Spray is a white, uniform suspension contained in an amber glass bottle, fitted with a metering (50 µL) atomising spray pump. This inner pack is incorporated within a predominantly off-white plastic device with a blue side-actuated lever and a lid which contains a stopper. Each spray of the suspension delivers approximately 27.5 micrograms of micronised fluticasone furoate as an ex-device dose.

PHARMACEUTICAL FORM
Nasal spray, suspension

CLINICAL PARTICULARS
Indications
Adults, Adolescents (12 years and over) and children (6-11 years)
Avamys is indicated for the treatment of :
the symptoms of allergic rhinitis.



Dosage and Administration
AVAMYS  Nasal Spray is for administration by the intranasal route only. For full therapeutic benefit regular scheduled usage is recommended. Onset of action has been observed as early as 8 hours after initial administration. It may take several days of treatment to achieve maximum benefit, and the patient should be informed that their symptoms will improve with continuous regular use. The duration of treatment should be restricted to the period that corresponds to allergic exposure.

Sumber : Badan POM RI